𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advances in prostate cancer immunotherapy

✍ Scribed by E.G. Havranek; M.A. Whelan; R. Greenhalgh; A.G. Dalgleish; H. Pandha

Book ID
114315127
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
159 KB
Volume
11
Category
Article
ISSN
0960-7404

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Integrated data from 2 randomized, doubl
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
✍ Celestia S. Higano; Paul F. Schellhammer; Eric J. Small; Patrick A. Burch; John πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 402 KB

## Abstract ## BACKGROUND: Sipuleucel‐T is an investigational active cellular immunotherapy product designed to stimulate an immune response against prostate cancer. The safety and efficacy of sipuleucel‐T was evaluated in 2 identically designed, randomized, double‐blind, placebo‐controlled trials

Advances in cancer immunotherapy
Advances in cancer immunotherapy
✍ Ockert, Detlef (author);Schmitz, Marc (author);Hampl, Monika (author);Rieber, Er πŸ“‚ Article πŸ“… 1999 πŸ› Elsevier Ltd 🌐 English βš– 141 KB
Advances in cancer immunotherapy
Advances in cancer immunotherapy
✍ Ockert, Detlef (author);Schmitz, Marc (author);Hampl, Monika (author);Rieber, Er πŸ“‚ Article πŸ“… 1999 πŸ› Elsevier Ltd 🌐 English βš– 141 KB